The document discusses various primary immunodeficiency syndromes including T cell deficiencies like DiGeorge syndrome and X-linked hyper IgM syndrome. It also covers combined B- and T-cell immunodeficiencies such as severe combined immunodeficiency disease (SCID) as well as acquired immunodeficiency diseases and diseases of immune dysregulation including hemophagocytic lymphohistiocytosis (HLH), X-linked lymphoproliferative syndrome, and HIV/AIDS. Treatment options discussed include bone marrow transplantation, gene therapy, and highly active antiretroviral therapy. Outcomes for children with immunodeficiencies depend on timely diagnosis, adequate treatment and surveillance, and the underlying disease.
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service Chennai
Immunodeficiency Syndromes Part Three
1. Immunodeficiency Syndromes
Part Three
T cell Deficiencies, Combined B- and T-cell
Immunodeficiency, Acquired Immunodeficiency
Disease and diseases of Immune Dysregulation
April 23, 2013
Roy C. Maynard, M.D.
2. Review – Part Two
Deficiencies of innate immune
system and other well-defined
immunodeficiency syndrome
January 23, 2013
2
3. Conclusions – Part Two
• Immunodeficiency disorders are fairly
infrequent
• Some are transient with improvement over
time
• More severe forms of immunodeficiency
are associated with shortened life span
without bone marrow transplantation
• A genetic cause has been identified for a
substantial portion of these disorders
3
4. Conclusions – Part Two
• Treatment options include:
– Prophylactic antibiotics
– SQ gammaglobulin
– IV gammaglobulin
– Stem cell or bone marrow transplantation
– New biologicals
– Gene therapy
4
5. Immunodeficiency Syndromes
Part Three
T cell Deficiencies
Combined B- and T-cell Immunodeficiency
Acquired Immunodeficiency Disease
Diseases of Immune Dysregulation
5
6. Objectives
• Understand aspects of the immune system
affected in severe combined
immunodeficiency disease
• Identify some of the features of
Hemophagocytic Lymphohistiocytosis
(HLH)
• Describe how retroviruses replicate in HIV
disease
7. Objectives
• Primary T-cell defect
– DiGeorge syndrome
– X-linked hyperIgM syndrome
• T and B cell defect – SCID
• Disorders of Immune Dysregulation
– HLH
– X-linked lymphoproliferative syndrome
• HIV
11. DiGeorge Syndrome
• Laboratory
– Hypocalcemia
– Hypoparathyroidism
– Absent thymus on CXR
– Decreased circulating T-cells
– Decreased T-cell response
– Deletion long arm chromosome 22
– Primarily a T-cell defect
12. X-linked Hyper IgM Syndrome
• Males – 2 per million
• CD40L deficiency
• CD40L is on surface of activated T-cells
• Activated T-cells use CD40L to interact
with B cells to switch from IgM production
to IgG production
• Increased IgM, decreased IgG
13. Severe Combined
Immunodeficiency Disease (SCID)
• Clinical
– Most severe form of primary
immunodeficiency
– 1/80,000 births
– Failure to thrive, chronic diarrhea
– Recurrent infections, pneumocystis
pneumonia
14. SCID
• Newborn screening
• Genetic mutations affect both T and B
cells in adaptive immune system
– X-linked (most common)
– Autosomal recessive
– De novo mutations
– Adenosine deaminase deficiency
– Omenn syndrome (RAG genes)
15. Newborn Screening for SCID
http://idfscidnewbornscreening.org/wp-content/uploads/2011/07/SCID-NBS-map.jpg
Accessed on 4/22/13 - Images
22. Hemophagocytic
Lymphohistiocytosis (HLH)
• Laboratory
– 1.2 cases/million (rare)
– All age groups: younger more likely genetic
(primary)
– Pancytopenia
– Elevated ferritin levels
– Elevated sIL-2r
– Histopathology: activated macrophages ingest
RBC’s, WBC’s and platelets
23. Distribution of Primary
Immunodeficiency Diseases
http://www.biomedsearch.com/attachments/00/21/17/05/21170549/431_2010_1358_Fig1_HTML.jpg
Accessed on 1/22/13 - Images
23
26. Outcome for HLH
• Without treatment, patients with familial
HLH survived two months
• In 1994, reported survival was 55% with
median follow-up at 3.1 years
• Before 2000, survival after bone marrow
transplantation was 50 to 65%
• Outcome may now be better with
improved treatment regimens
27. X-linked Lymphoploliferative
Syndrome
• Long arm X chromosome
• SH2D1A gene, XIAP gene (X-linked
recessive)
• 1 male per million
• Epstein-Barr Virus (EBV) triggers
hemophagocytic lymphohistiocytosis
• Lymphoma
• Treatment: stem cell transplant
29. HIV History
• Africa early 20th century
• Primates infected with SIV (simian
immunodeficiency virus)
• Bushmeat infected humans with SIV and
virus mutates into HIV
• Urbanization and increased STD promotes
spread in Africa
• Virus introduced into the US in 1969?
30. HIV History
• Increasing reports of a previously
unknown disease reported after 1969 in
US
• In 1981, disease confirmed in US
• In 1982, the disease is named AIDS
(acquired immunodeficiency syndrome)
• In 1983, report published in SCIENCE
identifying HIV as a retrovirus
31. Epidemiology
• 30 million deaths by 2009
• 34 million living with HIV/AIDS worldwide
• In US in 2008, 1.2 million living with HIV
infection
• Sixth leading cause of death in ages 25 –
44 in US
33. HIV
• Single stranded RNA virus
• Viral encoded reverse transcriptase makes
double stranded DNA
• Viral integrase allows viral DNA to be
spliced into human DNA
• May remain dormant or code for new
viruses to be made
• HIV-1, HIV-2
34. Transmission
• Blood transfusion
• Sexual contact
• Vertical transmission – mother to baby
• IV drug abuse
• Body fluid exposure only if contaminated
with blood
• Breast milk
• Organ transplantation
• Needle stick
35. Pathophysiology
• Enters the body and get viral replication
• Virus attaches to T lymphocytes,
macrophages
• CD4+ cells (helper) depleted at expense of
CD8+ (suppressor) cell activation
• Eventually majority of CD4+ cells are lost
and immune system partially disabled
leading to oppurtunistic infections and
cancer
36. Clinical – Three Stages
• Acute Infection
• Latency Period
• Acquired Immunodeficiency Syndrome
40. Clinical
• Acquired Immunodeficiency Syndrome
– Defined as CD4+ counts<200 or intercurrent
diseases associated with HIV infection
(pneumocystis pneumonia, Kaposi’s sarcoma)
– Occurs in 50% of HIV + individuals within 10
years of infection if not treated
41. Treatment
• HAART- highly active antiretroviral therapy
– DNA analogs: reverse transcriptase inhibitors
– Non DNA analogs: bind to enzyme (reverse
transcriptase) and cause conformational
change so cannot make DNA
43. Conclusion
• Outcomes for children with
immunodeficiency dependent depends on
the following:
– Timely recognition
– Adequate therapy and surveillance
– The nature of the underlying disease
44. Thank you for attending
• Immunodeficiency Syndromes, Part Three
– T cell Deficiencies
– Combined B- and T-cell Immunodeficiency
– Acquired Immunodeficiency Disease Diseases of
Immune Dysregulation